| 824 | 18 | 66 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:基于中医传承辅助平台分析张洪春教授治疗慢性阻塞性肺疾病稳定期患者的用药规律。方法:收集整理张洪春教授治疗慢阻肺稳定期患者的处方,对其进行频数统计、关联规则、复杂系统熵聚类等分析。结果:共筛选出111诊次处方,包含中药100味,药性以温、寒、平为主,药味以甘、苦、辛为主,归经多归属于肺、脾、肝、肾经,提取药物核心组合34个,置信度为1的关联规则38条,得到新处方3个,核心处方为:当归15 g、太子参30 g、山茱萸15 g、五味子15 g、款冬花15 g、紫菀15 g、茯苓15 g、紫苏子15 g、紫苏叶15g、麻黄10 g、甘草3 g。结论:张洪春教授以补益肺脾肾为基本治法,兼以止咳化痰平喘、行气活血散瘀来治疗慢阻肺稳定期患者。
Abstract:Objective:To analyze the medication rule of Professor Zhang Hongchun in treating patients with chronic obstructive pulmonary diseases(COPD)during stable period based on the Traditional Chinese Medicine Inheritance Support System. Methods:The prescriptions of Professor Zhang Hongchun in treating stable COPD patients were collected and analyzed for their frequency statistics,association rules and complex system entropy clustering. Results:A total of 111 prescriptions were screened out,including 100 kinds of traditional Chinese medicine,which were mainly warm,cold and mild in nature,and sweet,bitter and pungent in flavor. The meridians were mostly attributed to the lung,spleen,liver and kidney. A total of 34 core combinations of drugs were extracted,and 38 association rules with confidence level of one were obtained. Moreover,3 new prescriptions were obtained. The core prescriptions included:Angelicae sinensis radix(15 g),Radix pseudostellariae(30 g),Cornus officinalis Sieb. et Zucc.(15 g),Schisandrae chinensis fructus(15 g),Farfarae flos(15 g),Asteris radix et rhizoma(15 g),Poria cocos(Schw.)Wolf(15 g),Perillae fructus(15 g),Perilla frutescens(15 g),Ephedra herba(10 g),and licorice(3 g).Conclusion:Professor Zhang Hongchun's treatment methods of stable COPD patients are to invigorate the lung,spleen and kidney,stop cough,eliminate phlegm and asthma,promote Qi,activate blood circulation and dissipate blood stasis.
1 Global Initiative for Chronic Obstructive Lung Disease.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease(2020Report)[EB/OL].(2019-11-05)[2020-10-08]https://goldcopd.org/gold-reports/.
2 Wang C,Xu J,Yang L,et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China(the China Pulmonary Health[CPH]study):A national cross-sectional study[J]. Lancet,2018,391(10131):1706-1717.
3 陆彩云.慢性阻塞性肺疾病治疗研究进展[J].广西中医药大学学报,2019,22(2):59-62.
4 樊长征,苗青,樊茂蓉,等.慢性阻塞性肺疾病稳定期中医临床实践指南(征求意见稿)[J].中国中药杂志,2020,45(22):5309-5322.
5 赵丹,来薛,唐佳金,等.张洪春教授诊治咳喘经验[J].中华中医药学刊,2011,29(7):1472-1473.
6 唐仕欢,申丹,卢朋,等.中医传承辅助平台应用评述[J].中华中医药杂志,2015,30(2):329-331.
7 钟赣生.中药学[M]. 10版.北京:中国中医药出版社,2016.
8 刘嘉琪,阚诗云,朱雪,等.慢性阻塞性肺疾病中医证候演变规律研究概述[J].辽宁中医药大学学报,2019,21(1):76-79.
9 董培良,李慧,韩华.当归及其药对的研究进展[J].中医药信息,2019,36(2):127-130.
10 周迎春,张廉洁,张燕丽.山茱萸化学成分及药理作用研究新进展[J].中医药信息,2020,37(1):114-120.
11 黄世敬,陈宇霞,张颖,等.五味子抗抑郁应用与研究[J].辽宁中医杂志,2015,42(7):1294-1296.
12 范玲,王鑫,朱晓静,等.紫菀化学成分及药理作用研究进展[J].吉林中医药,2019,39(2):269-273.
13 侯阿娇,郭新月,满文静,等.款冬花的化学成分及药理作用研究进展[J].中医药信息,2019,36(1):107-112.
14 马屏南.紫苏子镇咳、祛痰、平喘作用的药理研究[J].中国实用医药,2015,10(10):159-160.
15 何育佩,郝二伟,谢金玲,等.紫苏药理作用及其化学物质基础研究进展[J].中草药,2018,49(16):3957-3968.
16 张梦婷,张嘉丽,任阳阳,等.麻黄的研究进展[J].世界中医药,2016,11(9):1917-1921,1928.
17 王辛秋,张洪春,陈燕.晁恩祥辨治“风咳”经验介绍[J].北京中医药,2010,29(9):667-668.
基本信息:
DOI:10.13210/j.cnki.jhmu.20210222.001
中图分类号:R249;R259
引用信息:
[1]刘迪,张巍,张洪春.张洪春教授治疗慢阻肺稳定期用药规律探析[J].海南医学院学报,2021,27(14):1104-1108+1115.DOI:10.13210/j.cnki.jhmu.20210222.001.
基金信息:
中医药传承与创新“百千万”人才工程(岐黄工程)(2019-QTL-003)~~
2021-02-22
2021-02-22
2021-02-22